keyword
Keywords radiofrequency ablation colore...

radiofrequency ablation colorectal liver

https://read.qxmd.com/read/37491521/the-added-diagnostic-value-of-transcatheter-ct-hepatic-arteriography-for-intraprocedural-detection-of-previously-unknown-colorectal-liver-metastases-during-percutaneous-ablation-and-impact-on-the-definitive-treatment-plan
#21
JOURNAL ARTICLE
Susan van der Lei, Jip Opperman, Madelon Dijkstra, Nikita Kors, Rianne Boon, Bente A T van den Bemd, Florentine E F Timmer, Irene M G C Nota, Janneke E van den Bergh, Jan J J de Vries, Hester J Scheffer, Bart Geboers, Timothy Neuss, Evelien Schouten, Birgit I Lissenberg-Witte, Robbert S Puijk, Martijn R Meijerink
PURPOSE: This study assessed the diagnostic value of CT hepatic arteriography (CTHA) for the intraprocedural detection of previously unknown colorectal liver metastases (CRLM) and the impact on the definitive treatment plan. MATERIALS AND METHODS: All patients treated with CTHA-guided percutaneous ablation for CRLM between January 2012 and March 2022 were identified from the Amsterdam Colorectal Liver Met Registry (AmCORE). Radiology reports of the ablative procedure and follow-up imaging were reviewed to see if (a) previously unknown CRLM were detected intra-procedurally and if (b) new CRLM, potentially missed on CTHA, appeared within 6 months following the procedure; three abdominal radiologists re-reviewed the baseline CTHA scans of these patients with early recurrence...
July 25, 2023: Cardiovascular and Interventional Radiology
https://read.qxmd.com/read/37480350/simultaneous-approach-of-colo-rectal-and-hepatic-lesions-in-colo-rectal-cancers-with-liver-metastasis-a-single-oncological-center-overview
#22
JOURNAL ARTICLE
Laurenţiu Simion, Vlad Rotaru, Simona Cirimbei, Elena Chitoran, Laurenţia Galeş, Dan Cristian Luca, Sînziana Ionescu, Bogdan Tanase, Octav Ginghină, Alecu Mihnea, Silviu Voinea, Andra Bîrligea, Horia Doran, Ciprian Cirimbei
Introduction: Management of synchronous colorectal cancer with liver metastases (SCLM) is still on debate, regarding timing, indications and complications of the 3 strategies: classic approach (first tumor resection), simultaneous resection and reverse approach (liver first). A retrospective single-centre evaluation of synchronous approach was accomplished, focusing on surgical technique, indications and complications. Material and Methods: Between 2017 and 2020, 31 SCLM patients benefited from synchronously colorectal and hepatic approach: segmental colectomies/rectal resections, simultaneously with liver metastasectomies (associated with radiofrequency ablation)...
June 2023: Chirurgia
https://read.qxmd.com/read/37480349/the-survival-benefit-of-repetitive-ultrasound-guided-liver-resections-in-the-absence-of-chemotherapy-for-multiple-colorectal-recurrent-liver-metastases
#23
JOURNAL ARTICLE
Alin Kraft, Alexandru Bârcu, Darina Barzan, Radu Dumitru, Adina Croitoru, Vlad Herlea, Irinel Popescu, Florin Botea
We present the case of a 54-year-old female patient, diagnosed with stage IV rectal cancer, with multiple (12) synchronous liver metastases, the largest of 10 cm in diameter, bilobar distributed. The operative management consisted in simultaneous ultra-low robotic anterior resection with coloanal anastomosis (protected by ileostomy) and multiple ultrasound-guided non-anatomical liver resections (in open approach). The patient was unable to follow neoadjuvant and adjuvant chemotherapy due to the systemic side effects...
June 2023: Chirurgia
https://read.qxmd.com/read/37479137/efficacy-of-microwave-ablation-versus-radiofrequency-ablation-in-the-treatment-of-colorectal-liver-metastases-a-systematic-review-and-meta-analysis
#24
REVIEW
Yu Tang, Hai Zhong, Ying-Ying Wang, Jian-Xiang Wu, Jian-Chun Zheng
OBJECTIVE: To study the efficacy of microwave ablation (MWA) and radiofrequency ablation (RFA) for colorectal liver metastases (CRLM) by meta-analysis. METHODS: PubMed, Web of Science, Embase, CNKI and the Cochrane Library were searched from the establishment to May 2023, and studies that report outcomes with comparison between MWA and RFA in CRLM treatment were selected by inclusion and exclusion criteria. Furthermore, the perioperative and survival data were statistically summarized and analyzed by Review Manager 5...
July 19, 2023: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/37427169/systemic-chemotherapy-combined-with-radiofrequency-ablation-for-colorectal-cancer-with-liver-metastasis-a-retrospective-cohort-study
#25
JOURNAL ARTICLE
Thang Tran, Hoa Thi Nguyen, Giang Hoang Pham, Cuc Thi Hoang, Quan Duc Vu
UNLABELLED: This study aims to evaluate the efficacy of systemic chemotherapy combined with radiofrequency ablation in the treatment of inoperable colorectal cancer with liver metastasis. MATERIALS AND METHODS: The authors conducted a retrospective cohort analysis on 30 patients diagnosed as colorectal cancer with liver metastasis who underwent systemic chemotherapy combined with radiofrequency ablation of the liver lesions from January 2017 to August 2020 at our institution...
July 2023: Annals of Medicine and Surgery
https://read.qxmd.com/read/37351979/a-systematic-review-of-microwave-ablation-for-colorectal-pulmonary-metastases
#26
REVIEW
Charis Q Y Tan, Andy Ho, Hayden A Robinson, Linna Huang, Praveen Ravindran, Daniel L Chan, Nayef Alzahrani, David L Morris
BACKGROUND/AIM: Pulmonary metastases are the second most common site of metastasis in colorectal cancer after the liver, and microwave ablation (MWA) for its treatment has grown in popularity in patients who are not suitable for pulmonary metastatectomy. However, its long-term efficacy remains unknown. MATERIALS AND METHODS: A systematic review was conducted in July 2022 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, using PubMed, EMBASE, Scopus, and Cochrane databases...
July 2023: Anticancer Research
https://read.qxmd.com/read/37348786/radiofrequency-ablation-induced-tumor-growth-is-suppressed-by-microrna21-inhibition-in-murine-models-of-intrahepatic-colorectal-carcinoma
#27
JOURNAL ARTICLE
Lukas Salvermoser, S Nahum Goldberg, Flinn Laville, Aurelia Markezana, Matthias Stechele, Muneeb Ahmed, Moritz Wildgruber, Philipp M Kazmierczak, Marianna Alunni-Fabbroni, Eithan Galun, Jens Ricke, Mor Paldor
PURPOSE: To investigate the role of microRNA21 (miR21) in RFA (radiofrequency ablation)-induced tumor growth, and whether miR21 inhibition suppresses tumorigenesis. MATERIAL AND METHODS: Standardized liver RFA was applied to 35 C57/BL6 mice. miR21 and target proteins pSTAT3 (phosphorylated signal transducer/activator of transcription 3), PDCD4 (programmed cell death protein 4), and PTEN (phosphatase and tensin homolog) were assayed 3hr, 24hr, and 3d post-ablation...
June 20, 2023: Journal of Vascular and Interventional Radiology: JVIR
https://read.qxmd.com/read/37337360/ablation-therapy-for-patients-with-colorectal-liver-metastases-with-and-without-extrahepatic-metastases-evaluation-of-long-term-outcomes-and-prognostic-factors
#28
JOURNAL ARTICLE
Jeanett Klubien, Jacob Rosenberg, Bjørn Ole Skjoldbye, Torben Lorentzen, Christian Pállson Nolsøe, Hans-Christian Lykkegaard Pommergaard
PURPOSE: Ablation is a valuable treatment alternative to surgery for colorectal liver metastases. This study reports the long-term clinical outcomes in patients treated with ablation for colorectal liver metastases with or without extrahepatic metastases. METHODS: Patients with colorectal liver metastases treated with ultrasound-guided ablation at Herlev Hospital, Denmark were included in this retrospective study. RESULTS: This study included 284 patients with 582 metastases...
March 28, 2023: Ultrasonography
https://read.qxmd.com/read/37325970/treatment-outcome-comparisons-of-first-line-targeted-therapy-in-patients-with-kras-wild-type-metastatic-colorectal-cancer-a-nationwide-database-study
#29
JOURNAL ARTICLE
Yi-Hsin Liang, Kuo-Hsing Chen, Yu-Yun Shao
BACKGROUND: The first-line systemic therapy for metastatic colorectal cancer (mCRC) is a combination of one targeted therapy agent and a chemotherapy doublet. Whether bevacizumab or anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibody (mAb) is the more effective addition to a chemotherapy doublet as the first-line treatment for inoperable KRAS wild-type mCRC remains controversial in prior clinical trials. Moreover, the association between the sidedness of primary tumors and the efficacy of anti-EGFR mAb needs to be addressed...
June 16, 2023: Cancer Medicine
https://read.qxmd.com/read/37322315/colorectal-cancer-with-synchronous-unresectable-liver-metastases-resecting-the-primary-tumor-improves-survival
#30
JOURNAL ARTICLE
Nicola Leone, Simone Arolfo, Rosella Spadi, Maria Roberta Fortunato, Roberto Passera, Mario Morino
PURPOSE: The optimal treatment strategy of patients affected by colorectal cancer (CRC) with synchronous unresectable liver metastases (SULM) is at present undefined. It is not known if a palliative primary tumor resection followed by chemotherapy could have a survival benefit compared to upfront chemotherapy (CT). The aim of the study is to analyze the safety and effectiveness of both therapeutic strategies in a group of patients treated at one institution. METHODS: A prospectively collected database was queried for patients affected by colorectal cancer with synchronous unresectable liver metastases between January 2004 and December 2018, defining and comparing 2 groups: patients treated by chemotherapy alone (group 1) vs patients who underwent primary tumor resection with or without a first line chemotherapy (group 2)...
June 15, 2023: International Journal of Colorectal Disease
https://read.qxmd.com/read/37232461/radiofrequency-ablation-for-colorectal-cancer-liver-metastases-outcomes-and-prognostic-factors-associated-with-survival
#31
JOURNAL ARTICLE
Okan Akhan, Seray Akçalar, Emre Ünal, Yavuz Metin, Türkmen Çiftçi, Devrim Akıncı
BACKGROUND: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases. Additionally, we sought to examine whether various patient- and treatment-related characteristics were associated with prognosis. METHODS: Fifty-nine patients with colorectal cancer liver metastases who had undergone percutaneous radiofrequency ablation treatment were included in this study...
May 26, 2023: Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology
https://read.qxmd.com/read/37191629/comparison-of-the-therapeutic-efficacy-between-systemic-chemotherapy-with-and-without-radiofrequency-ablation-for-colorectal-cancer-liver-metastases-a-propensity-score-matching-study
#32
JOURNAL ARTICLE
Wu Hao, Zhou Jun, Li Yan, Zhang Zhong-Yi, Jiang Bin-Bin, Liu Gui-Ju, Yang Wei, Shen Lin, Yan Kun
OBJECTIVE: To compare therapeutic efficacy between systemic chemotherapy (SC) alone and preoperative SC followed by radiofrequency ablation (SC+RFA) in patients with colorectal cancer liver metastases (CRLM). METHODS: This study identified a cohort of patients with CRLM after treatment between 2010 and 2016. Patients who received SC+RFA were compared with SC patients by propensity score matching. Overall survival (OS) and intrahepatic progression-free survival (PFS) were compared using stratified log-rank test...
May 16, 2023: British Journal of Radiology
https://read.qxmd.com/read/37183198/combining-radiofrequency-ablation-with-hepatic-resection-for-liver-only-colorectal-metastases-a-propensity-score-based-analysis-of-long-term-outcomes
#33
JOURNAL ARTICLE
Fabio Giannone, Aurélien Grollemund, Emanuele Felli, Theo Mayer, Zineb Cherkaoui, Catherine Schuster, Patrick Pessaux
BACKGROUND: Combining liver resection (LR) with radiofrequency ablation (RFA) is nowadays an accepted option for treating colorectal liver metastases (CRLMs), but the number of lesions ablated is regularly described as a recurrence risk factor. In this study, we report our experience and determine the impact of RFA on long-term outcomes. METHOD: This is a retrospective study including patients undergoing LR with or without RFA for CRLM. All variables influencing disease-free survival (DFS) and disease-specific survival (DSS) were examined through a Cox regression analysis before and after propensity-score matching (PSM)...
May 15, 2023: Annals of Surgical Oncology
https://read.qxmd.com/read/37038666/the-short-term-efficacy-of-contrast-enhanced-ultrasound-ceus-and-gd-eob-dtpa-enhanced-magnetic-resonance-imaging-mri-fusion-imaging-guided-radiofrequency-ablation-rfa-for-colorectal-liver-metastasis-crlm
#34
JOURNAL ARTICLE
Lei Li, Lei Zhang, Xue Han, Xintong Li, Huajing Yang, Ya-Nan Sun, Wen Cheng
OBJECTIVE: This study is to explore the efficacy of contrast-enhanced ultrasound (CEUS) / Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) fusion imaging-guided(fusion group)radiofrequency ablation (RFA) versus conventional ultrasound imaging-guided (conventional group) RFA for colorectal cancer liver metastases (CRLM) in a short-term. METHODS: From December 2020 to December 2021, patients who underwent imaging-guided RFA of CRLM at our hospital with available CT/MRI images were enrolled consecutively...
April 5, 2023: Current medical imaging
https://read.qxmd.com/read/37004464/economic-evaluation-of-18f-fdg-pet-ct-mri-and-ce-ct-in-selection-of-colorectal-liver-metastases-eligible-for-ablation-a-cost-effectiveness-analysis
#35
JOURNAL ARTICLE
Moritz L Schnitzer, Janine Buchner, Gloria Biechele, Freba Grawe, Maria Ingenerf, Niklas von Münchhausen, Clemens G Kaiser, Wolfgang G Kunz, Matthias F Froelich, Christine Schmid-Tannwald, Johannes Rübenthaler
OBJECTIVES: Colorectal cancers (CRC) are among the world's most prevailing cancer entities. In a third of all cases, the patients have already developed distant metastases - mainly in the liver - at the time of detection. Colorectal liver metastases (CRLM) can be treated by surgical resection or, as is possible in most cases, by percutaneous ablation. For selecting the liver metastases eligible for radiofrequency ablation (RFA) or microwave ablation (MWA), the common imaging modalities are magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT), and contrast-enhanced computed tomography (CE-CT)...
March 30, 2023: European Journal of Radiology
https://read.qxmd.com/read/36994643/long-term-results-of-liver-thermal-ablation-in-patients-with-hepatocellular-carcinoma-and-colorectal-cancer-liver-metastasis-regarding-spatial-features-and-tumor-specific-variables
#36
JOURNAL ARTICLE
Okan Akhan, Ahmet Gürkan Erdemir, Sevilay Karahan, Emre Ünal, Türkmen Turan Çiftçi, Devrim Akıncı, Şuayib Yalçın
PURPOSE: Colorectal cancer liver metastasis (CRLM) and hepatocellular carcinoma (HCC) are widely treated using microwave and radiofrequency ablation. Local tumor progression (LTP) may develop depending on the shortest vascular distance and large lesion diameter. This study aims to explore the effect of these spatial features and to investigate the correlation between tumor-specific variables and LTP. METHODS: This is a retrospective study covering the period between January 2007 and January 2019...
March 20, 2023: Diagnostic and Interventional Radiology: Official Journal of the Turkish Society of Radiology
https://read.qxmd.com/read/36976117/predictive-factors-of-local-recurrence-after-colorectal-cancer-liver-metastases-thermal-ablation
#37
JOURNAL ARTICLE
Julien Odet, Julie Pellegrinelli, Olivier Varbedian, Caroline Truntzer, Marco Midulla, François Ghiringhelli, David Orry
BACKGROUND: Identify risk factors for local recurrence (LR) after radiofrequency (RFA) and microwave (MWA) thermoablations (TA) of colorectal cancer liver metastases (CCLM). METHODS: Uni- (Pearson's Chi2 test, Fisher's exact test, Wilcoxon test) and multivariate analyses (LASSO logistic regressions) of every patient treated with MWA or RFA (percutaneously and surgically) from January 2015 to April 2021 in Centre Georges François Leclerc in Dijon, France. RESULTS: Fifty-four patients were treated with TA for 177 CCLM (159 surgically, 18 percutaneously)...
March 10, 2023: Journal of Imaging
https://read.qxmd.com/read/36960629/metastasis-directed-local-therapy-of-hepatic-oligometastasis-from-colorectal-cancer-and-future-perspective-in-radiation-therapy
#38
JOURNAL ARTICLE
Gyu Sang Yoo, Chai Hong Rim, Won Kyung Cho, Jae-Uk Jeong, Eui Kyu Chie, Hyeon-Min Cho, Jun Won Um, Yong Chan Ahn, Jong Hoon Lee
Introduction of the concept for oligometastasis (OM) led to wide application of metastasis-directed local ablative therapies for metastatic colorectal cancer (CRC). By application of the metastasis-directed local ablative therapies including surgical resection, radiofrequency ablation (RFA), and stereotactic ablative body radiotherapy (SABR), the survival outcomes of patients with metastatic CRC have improved. The liver is the most common distant metastatic site in CRC patients, and recently various metastasis-directed local therapies for hepatic oligometastasis from CRC (HOCRC) are widely used...
March 17, 2023: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/36936255/clinical-outcomes-of-radiofrequency-ablation-combined-with-transarterial-chemoembolization-using-degradable-starch-microsphere-mixed-with-mitomycin-c-for-the-treatment-of-non-hepatocellular-carcinoma-malignant-liver-tumors
#39
JOURNAL ARTICLE
Terutaka Yoshihara, Takaaki Hasegawa, Yozo Sato, Hidekazu Yamaura, Shinichi Murata, Shohei Chatani, Ryota Tsukii, Kyohei Nagasawa, Yoshito Tsushima, Yoshitaka Inaba
PURPOSE: To retrospectively evaluate the outcomes of radiofrequency ablation combined with transarterial chemoembolization using degradable starch microspheres for non-hepatocellular carcinoma malignant liver tumors. MATERIAL AND METHODS: A total of 15 patients (13 men, 2 women; median age, 67 years) who underwent radiofrequency ablation immediately after transarterial chemoembolization using degradable starch microspheres for liver tumors between July 2011 and September 2020 were included in this study...
March 1, 2023: Interventional radiology
https://read.qxmd.com/read/36929352/local-interventions-for-colorectal-cancer-metastases-to-liver-and-lung
#40
JOURNAL ARTICLE
Melih Simsek, Mehmet Besiroglu, Adem Akcakaya, Atakan Topcu, Ayse Irem Yasin, Zehra Sucuoglu Isleyen, Mesut Seker, Haci Mehmet Turk
BACKGROUND: Colorectal cancer is a common cause of cancer-related deaths. About 1/3 of all cases present with distant metastasis, with the liver as the leading site and the lung as the most common extra-abdominal site. AIMS: It was aimed to evaluate the clinical characteristics and the outcomes of colorectal cancer patients with liver or lung metastasis who had received local treatments. METHODS: This is a retrospective, cross-sectional, and descriptive study...
March 17, 2023: Irish Journal of Medical Science
keyword
keyword
109350
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.